Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.89 |
| ▸ | CHAT | P28329 | 2/20 | 0.85 |
| ▸ | EP300 | Q09472 | 3/20 | 0.84 |
| ▸ | AURKA | O14965 | 2/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.84 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27771356 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL12409230 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL119813 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL29238961 | 0.96 | NAA50 (0.88) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL30221123 | 0.96 | NAA50 (0.88) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL7524149 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL12018856 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL30508930 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL30508932 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL4657682 | 0.96 | NAA50 (0.82) | NAA50CHATEP300AURKAKAT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102146-A1 | METHOD AND APPARATUS FOR MANAGING AEROBIC GAS FERMENTATION | LANZATECH, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026101463-A2 | PRODUCTION OF METHACRYLIC ACID AND METHYL-METHACRYLATE VIA CONDENSATION OF ACETONE AND FORMYL-COA | MOJIA BIOTECH PTE. LTD. (SG) | 2026-05-15 | — | — | WO | disclosed |
| EP-3362567-B1 | GENETICALLY ENGINEERED BACTERIUM COMPRISING ENERGY-GENERATING FERMENTATION PATHWAY | LANZATECH NZ INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | GENOMATICA, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4662192-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | Genomatica, Inc. (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-4649157-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | Mojia Biotech Pte. Ltd. (SG) | 2025-11-19 | — | — | EP | disclosed |
| WO-2025128739-A1 | NOVEL STRAINS AND METHODS FOR THE CONTINUOUS PRODUCTION OF A NUTRITIVE COMPOSITION | LANZATECH, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128740-A1 | SINGLE CELL PROTEIN WITH ENHANCED POLYUNSATURATED FATTY ACID CONTENT | LANZATECH, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128743-A1 | SINGLE CELL PROTEIN WITH ENHANCED DIGESTIVE ENZYME CONTENT | LANZATECH, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128744-A1 | STRAINS AND METHODS FOR THE CONTINUOUS PRODUCTION OF PRODUCTS BY GAS FERMENTATION | LANZATECH, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20230126921-A1 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | AGAIN BIO APS (DK) | 2023-04-27 | — | — | US | disclosed |
| WO-2023004293-A1 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | LANZATECH, INC. (US) | 2023-01-26 | — | — | WO | disclosed |
| WO-2023004295-A1 | RECOMBINANT MICROORGANISMS AS A VERSATILE AND STABLE PLATFORM FOR PRODUCTION OF ANTIGEN-BINDING MOLECULES | LANZATECH, INC. (US) | 2023-01-26 | — | — | WO | disclosed |
| WO-2023287814-A2 | CARBOXYLIC ACID PLATFORM FOR FUEL AND CHEMICAL PRODUCTION AT HIGH CARBON AND ENERGY EFFICIENCY | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-01-19 | — | — | WO | disclosed |
| EP-4118090-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP Assets B.V. (NL) | 2023-01-18 | — | — | EP | disclosed |
| EP-4051657-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | Genomatica, Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-4048781-A1 | MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS | Genomatica, Inc. (US) | 2022-08-31 | — | — | EP | disclosed |
| CN-108698984-B | Bicyclic compounds for use as medicaments, in particular for the treatment of parkinson's disease | H·科斯特 | 2022-05-10 | — | — | CN | disclosed |
| EP-3980534-A1 | PRODUCTION OF 2-HYDROXYACYL-COAS AND DERIVATIVES THEREOF | Gonzalez, Ramon (US) | 2022-04-13 | — | — | EP | disclosed |
| WO-2022031859-A2 | METHYLMALONIC ACID AND METABOLISM THEREOF IS A CANCER BIOMARKER AND TARGET | CORNELL UNIVERSITY (US) | 2022-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | ALDOA, FDPS, DERA | NAA50 298/4885CHAT 1363/4885EP300 1390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.